Editorial: Multimorbidity in the context of neurodegenerative disorders
暂无分享,去创建一个
[1] W. Poewe,et al. Undetected ophthalmological disorders in Parkinson’s disease , 2022, Journal of Neurology.
[2] W. Oyen,et al. Medical imaging and nuclear medicine: a Lancet Oncology Commission. , 2021, The Lancet. Oncology.
[3] R. Linden,et al. Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer’s diseases , 2020, Journal of neurochemistry.
[4] J. Unger,et al. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation , 2019, JAMA oncology.
[5] S. Mtenga,et al. Multimorbidity , 2019, Nature Reviews Disease Primers.
[6] M. Habek,et al. Adrenergic hyperactivity: a missing link between multiple sclerosis and cardiovascular comorbidities? , 2018, Acta Neurologica Belgica.
[7] Jeffrey A. Cohen,et al. The challenge of comorbidity in clinical trials for multiple sclerosis , 2016, Neurology.
[8] Rokas Navickas,et al. Multimorbidity: What do we know? What should we do? , 2016, Journal of comorbidity.
[9] Ravi Varadhan,et al. Multimorbidity and Evidence Generation , 2014, Journal of General Internal Medicine.
[10] L. Fratiglioni,et al. Aging with multimorbidity: A systematic review of the literature , 2011, Ageing Research Reviews.
[11] Martin Fortin,et al. Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design? , 2010 .
[12] J. Oeppen. Life Expectancy Convergence Among Nations Since 1820: Separating the Effects of Technology and Income , 2019, Demographic Research Monographs.